GlassScriptPhysician profile
Louis Hernandez
NPI 1730295189
$5,294.44
in general payments reported to CMS, 2019-2025
31 companies · $921 in 2025
The $921 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $703 · 2021: $1,039 · 2022: $534 · 2023: $507 · 2024: $774 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,029.57 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $682.57 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $527.32 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Ardelyx, INC. | $370.92 | 2024-2025 | Ibsrela |
| Pfizer INC. | $370.30 | 2019-2024 | |
| Novo Nordisk INC | $276.18 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $250.84 | 2021-2025 | |
| Medtronic, INC. | $166.34 | 2024-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.64 | 2019-2025 | Relistor |
| Sanofi-Aventis U.S. LLC | $160.39 | 2019-2022 | |
| Lilly USA, LLC | $151.06 | 2019-2025 | Jardiance, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $142.36 | 2021-2025 | |
| Abiomed | $132.47 | 2023 | Impella |
| Janssen Pharmaceuticals, INC | $129.43 | 2021-2022 | |
| Abbott Laboratories | $84.79 | 2021-2025 | Freestyle Libre 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $82.91 | 2020-2024 | Otezla, Repatha |
| Allergan, INC. | $71.02 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $63.19 | 2019-2020 | |
| Mannkind Corporation | $61.59 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.83 | 2020 | |
| Merck Sharp & Dohme LLC | $51.86 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.72 | 2019-2021 | |
| Exact Sciences Corporation | $36.55 | 2023-2024 | Cologuard Collection Kit |
| Biodelivery Sciences International, INC. | $35.96 | 2021 | |
| Baxter Healthcare | $32.41 | 2024 | Hillrom - Monarch Airway Clearance System |
| Sunovion Pharmaceuticals INC. | $25.15 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $24.49 | 2022 | |
| Hologic Sales and Service, LLC | $23.81 | 2023 | Aptima, Thinprep 2000 Processor |
| Nevro Corp. | $21.96 | 2023 | Senza |
| Otsuka America Pharmaceutical, INC. | $17.76 | 2021 | |
| Shire North American Group INC | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.